| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.08 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.11 | 0.09 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.09 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.09 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.09 |